🎉 Match Day Recap 🎉
Congratulations to our MSTP class of 2025 - we are SO proud of you! Here’s where our four incredible graduates are headed:
Rose Caston - Neurosurgery at the University of Wisconsin
Michelle Culbertson - Pediatrics at the University of Utah
Sejal Mistry - Pediatrics | Physician Scientist Training Program at Stanford University
Raquel Zimmerman - Internal Medicine | Physician Scientist Training Program at the University of Utah
Enjoy these highlights from some of our favorite wellness and social events this semester — the annual MSTP takeover at Janet’s water aerobics class and brewery hang outs 🍺🏊🏼‍♀️
Last slide, best slide (no pun intended 🛝)
University of Utah MD-PhD class 2022!
@utahmdphd Mission
To train physician-scientists who will:
• integrate scientific discovery, translational applications and clinical practice
• become leaders whose contributions span all domains of service at academic health centers, industry and government
• serve as mentors and role models for future physician-scientist and leaders
Steve Cho, GS1 will present the attached article (https://pubmed.ncbi.nlm.nih.gov/30193113/) titled: “Post-Antibiotic Gut Mucosal Microbiome Reconstitution Is Impaired by Probiotics and Improved by Autologous FMT”. Specific Aims will be sent on Monday.
Parker Irvin, MS1 will give a short, trendy science presentation on the attached article (https://pubmed.ncbi.nlm.nih.gov/35777355/) titled: “A volatile from the skin microbiota of flavivirus-infected hosts promotes mosquito attractiveness”.
Welcome to @utahmdphd
Patrick Ozark, MS2 presented on the article (/doi/10.1073/pnas.2118740119) titled: “Advanced age increases frequencies of de novo mitochondrial mutations in macaque oocytes and somatic tissues7” on June 22, 2022. Thank you for sharing your scientific research interest in mitochondria.
Sammy Stone, MS2 will present the attached article (Targeting monoamine oxidase A for T cell–based cancer immunotherapy) titled: “Repurposing Monoamine Oxidase Inhibitors to restore anti-tumor immunity in immune checkpoint resistant tumors”.